Contraception: Clinical Trials

64 trials for Contraception, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed. 64 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 464Completed 64

Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception

Trials (filtered) newest first · largest first

All 64 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients
Depot-Medroxyprogestereone Acetate - Contraception
Phase 4CompletedNorthwestern University2632022-08-012026-10-15
Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
Norethindrone Acetate 5 MG, Norethindrone 0.35 MG - Contraception
Phase 4CompletedMilton S. Hershey Medical Center62022-07-222024-07-16
A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)
Paragard® T380A Intrauterine Copper Contraceptive with New Inserter - Contraception
Phase 4CompletedCooperSurgical Inc.1192022-03-042026-08-25
Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
Etonogestrel (ETG) implant, Intramuscular depo-medroxyprogesterone acetate (IM DMPA), Sub-cutaneous medroxyprogesterone acetate (SC MPA) - HIV Infections, Contraception
Phase 4CompletedUniversity of Alabama at Birmingham1102021-11-172025-04-08
Progestin-Only Pill Use and Breastfeeding Study
Progestin Only Contraceptive Pills - Contraception, Breastfeeding
Phase 4CompletedUniversity of California, San Diego302021-10-252024-04-19
Desogestrel-containing COCP Pharmacokinetic Validation Study
Desogestrel and Ethinyl Estradiol Tablets - Contraception
Phase 4CompletedUniversity of Colorado, Denver222021-09-102025-05-30
PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya
PrEP - HIV Infections, Contraception
Phase 4CompletedUniversity of Washington254572021-03-012025-09-04
Shoulder Contraceptive Implant Study
Etonogestrel implant - Contraception
Phase 4CompletedUniversity of Colorado, Denver52020-10-142023-06-08
Rifampin and the Contraceptive Implant
Rifampin 600 MG - Contraception, Tuberculosis
Phase 4CompletedUniversity of Colorado, Denver242020-09-232023-05-16
Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive
Etonogestrel contraceptive implant - Contraception
Phase 4CompletedUniversity of California, Davis1202020-08-132024-05-22
Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction
Cannabidiol Oil, Placebo, Combined oral contraceptive pill - Contraception
Phase 4CompletedOregon Health and Science University92020-04-082023-07-11
Breastfeeding Etonogestrel Implant Study
Etonogestrel, Nexplanon - Contraception
Phase 4CompletedUniversity of New Mexico1502019-06-032025-11-28
10% Lidocaine Spray for Intrauterine Device Insertion
lidocaine spray, Placebo - Contraception, Intrauterine Device
Phase 4CompletedMahidol University1242018-08-012020-01-30
Contraceptive Efficacy, Tolerance and Acceptability of a Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age
Benzalkonium Chloride Spermicide Cream - Contraception
Phase 4CompletedLaboratoire Innotech International1512017-12-262020-02-26
Sayana Press UK Self-Injection Study
Sayana Press - Contraception
Phase 4CompletedPfizer1692017-08-232019-10-18
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
UPA-ECx1, UPA-ECx2 - Obesity, Contraception
Phase 4CompletedOregon Health and Science University642017-05-302024-02-06
Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study
Etonogestrel contraceptive implant - Contraception
Phase 4CompletedUniversity of California, Davis202016-09-152018-12-28
RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
Copper IUD, Levonorgestrel IUD - Contraception
Phase 4CompletedUniversity of Utah7112016-08-012022-06-29
A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).
Levonorgestrel (13,5 mg) intrauterine device, Cooper (380mm2) intrauterine device - Contraception
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1082016-06-012021-10-28
YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
EE20/DRSP (YAZ, BAY86-5300) - Contraception
Phase 4CompletedBayer19212016-05-272019-06-28

Showing 20 of 64. Sign in to see all of them.

Narrower conditions

Body Weight (3)  ·  Breast Feeding (2)  ·  HIV Infections (2)  ·  Sexually Transmitted Diseases (2)  ·  Behavior (1)  ·  Depression, Postpartum (1)  ·  Epilepsy (1)  ·  Hemorrhage (1)  ·  Insulin Resistance (1)  ·  Menorrhagia (1)  ·  Obesity (1)  ·  Risk Reduction Behavior (1)  ·  Thrombosis (1)  ·  Tuberculosis (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (7)  ·  Urogenital Diseases (5)  ·  Genital Diseases (4)  ·  Infections (4)  ·  Pathologic Processes (4)  ·  Communicable Diseases (3)  ·  Signs and Symptoms (3)  ·  Behavior (2)  ·  Blood-Borne Infections (2)  ·  Disease Attributes (2)  ·  Feeding Behavior (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Lentivirus Infections (2)

Interventions

Levonorgestrel (12)  ·  etonogestrel (9)  ·  Ethinyl Estradiol (8)  ·  Medroxyprogesterone Acetate (5)  ·  Contraceptives, Oral (4)  ·  N,N-dimethyl-4-anisidine (3)  ·  Norethindrone (3)  ·  NuvaRing (3)  ·  ulipristal acetate (3)  ·  Contraception, Postcoital (2)  ·  Contraceptive Agents (2)  ·  Estrogens (2)  ·  Ethinyl Estradiol-Norgestrel Combination (2)  ·  Intrauterine Devices (2)  ·  Progesterone (2)

Sponsors

Oregon Health and Science University (7)  ·  Bayer (4)  ·  Columbia University (3)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  Organon and Co (3)  ·  University of Colorado, Denver (3)  ·  University of Sao Paulo (3)  ·  University of Utah (3)  ·  Pfizer (2)  ·  University of California, Davis (2)  ·  University of North Carolina, Chapel Hill (2)  ·  University of Pittsburgh (2)  ·  University of Washington (2)  ·  Beatrice Chen (1)  ·  Centers for Disease Control and Prevention (1)

Countries

United States (38)  ·  Brazil (5)  ·  France (4)  ·  Finland (2)  ·  Mexico (2)  ·  Canada (1)  ·  China (1)  ·  Ireland (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Russia (1)  ·  South Africa (1)  ·  Spain (1)  ·  Sweden (1)  ·  Thailand (1)

Top investigators

Carolina S Vieira, MD, PhD (3)  ·  Alison Edelman, MD, MPH (2)  ·  Alison Edelman, MD (1)  ·  Anita L Nelson, MD (1)  ·  Anna Wald, MD, MPH (1)  ·  Anne Davis, MD (1)  ·  Anne Davis, MD MPH (1)  ·  Annina Haverinen, MD, PhD student (1)  ·  Athena P Kourtis, MD, PhD, MPH (1)  ·  Carol Stamm, MD (1)  ·  Carolyn L Westhoff, MD (1)  ·  Carolyn L. Westhoff, MD, MSc (1)

Results publications

PMID 16102549, PMID 16394049, PMID 17067996, PMID 17540797, PMID 17714677, PMID 18238962, PMID 18313637, PMID 18360319, PMID 18395692, PMID 18468575, PMID 18685543, PMID 18976753, PMID 19245303, PMID 19935020, PMID 19955104, PMID 20378611, PMID 20472114, PMID 21514555, PMID 21651392, PMID 21843690, PMID 21860292, PMID 24560483, PMID 24682613, PMID 25487172, PMID 26942358, PMID 27000996, PMID 27554014, PMID 27607859, PMID 28594758, PMID 28692531, PMID 29457758, PMID 29470950, PMID 29496473, PMID 29746813, PMID 29920171, PMID 30529085, PMID 31145885, PMID 31299074, PMID 31374188, PMID 31950432, PMID 32303765, PMID 32591417, PMID 33478494, PMID 33503342, PMID 33706343, PMID 34259467, PMID 34895357, PMID 35909329, PMID 36084710, PMID 36416543

NIH funding

2005 (1), 2017 (1), K01TW009657 (1), K23HD078153 (1), R01MH123267 (1), R21AT002297 (1), U48DP001944 (1), U54HD042454 (1)